106 related articles for article (PubMed ID: 20673153)
1. The value of monitoring ciclosporin concentration 2 hours post-dose (C2) in dermatology: a prospective cohort study.
Chew AL; Bashir SJ; Johnston A; Barker JN; Smith CH
J Dermatolog Treat; 2011 Apr; 22(2):79-85. PubMed ID: 20673153
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
Bigby M
Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
[No Abstract] [Full Text] [Related]
3. Cyclosporine in the treatment of psoriasis.
Gulliver WP
Cutis; 2000 Nov; 66(5):365-9. PubMed ID: 11107522
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.
Flytström I; Stenberg B; Svensson A; Bergbrant IM
Br J Dermatol; 2008 Jan; 158(1):116-21. PubMed ID: 17986302
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
Aydin F; Canturk T; Senturk N; Turanli AY
Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
[TBL] [Abstract][Full Text] [Related]
6. Can cyclosporine blood level be reduced to half after heart transplantation?
Wang SS; Chou NK; Chi NH; Huang SC; Wu IH; Wang CH; Yu HY; Chen YS; Tsao CI; Ko WJ; Shun CT
Transplant Proc; 2010 Apr; 42(3):930-3. PubMed ID: 20430207
[TBL] [Abstract][Full Text] [Related]
7. Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis.
Kovalik M; Thoday KL; Handel IG; Bronsvoort BM; Evans H; van den Broek AH; Mellanby RJ
Vet Dermatol; 2011 Apr; 22(2):173-80. PubMed ID: 21114560
[TBL] [Abstract][Full Text] [Related]
8. High-concentration (20 μg g⁻¹ ) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial.
Choi JW; Choi JW; Kwon IH; Youn JI
Br J Dermatol; 2010 Jun; 162(6):1359-64. PubMed ID: 20302582
[TBL] [Abstract][Full Text] [Related]
9. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
[TBL] [Abstract][Full Text] [Related]
10. Pustular psoriasis of pregnancy treated with ciclosporin and high-dose prednisolone.
Edmonds EV; Morris SD; Short K; Bewley SJ; Eady RA
Clin Exp Dermatol; 2005 Nov; 30(6):709-10. PubMed ID: 16197395
[No Abstract] [Full Text] [Related]
11. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
13. The use of ciclosporin in psoriasis.
Berth-Jones J
J Dermatolog Treat; 2005; 16(5-6):258-77. PubMed ID: 16428145
[TBL] [Abstract][Full Text] [Related]
14. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
Midtvedt K; Fauchald P; Bergan S; Høieggen A; Hallan S; Svarstad E; Bergrem H; Eriksen BO; Pfeffer PF; Dalen I; Leivestad T
Transplantation; 2003 Oct; 76(8):1236-8. PubMed ID: 14578761
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis.
Hayama K; Inadomi T; Fujisawa D; Terui T
Eur J Dermatol; 2010; 20(6):758-62. PubMed ID: 21047721
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels.
Heydendael VM; Spuls PI; Ten Berge IJ; Opmeer BC; Bos JD; de Rie MA
Br J Dermatol; 2002 Jul; 147(1):122-9. PubMed ID: 12100194
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine in severe psoriasis: an Indian experience.
Kumar B; Sandhu K; Kaur I
Int J Dermatol; 2004 Aug; 43(8):623-4. PubMed ID: 15304194
[No Abstract] [Full Text] [Related]
19. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients.
Cantarovich M; Besner JG; Fitchett DH; Latter DA
Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930
[TBL] [Abstract][Full Text] [Related]
20. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
Kyllönen LE; Salmela KT
Transplantation; 2006 Apr; 81(7):1010-5. PubMed ID: 16612277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]